Literature DB >> 28032309

The General Expression Analysis of WTX Gene in Normal and Cancer Tissues.

Yao-Yao Zhang1,2, Qi-Ming Wang1,2, Hui-Lin Niu1,2, Xia Liu1,2, Qing-Ling Zhang3,4.   

Abstract

WTX (Wilms' tumor suppressor X chromosome) is a novel putative tumor suppressor gene in Wilms' tumor of kidney, its expression and function in other human cancers had not been explored. This study detected the expression of WTX in 459 cases of 15 organs of cancers and adjacent normal tissues by using immunohistochemical staining (IHC), and validated them by in situ hybridization (ISH) and quantitative real-time reverse transcription PCR (qRT-PCR). IHC and ISH data showed that WTX protein was generally expressed in normal tissues, but reduced expression in corresponding cancers. This study demonstrated that WTX downregulation is a common phenomenon in human cancers, WTX might be a general tumor-suppressor gene and biological marker of multiple cancer tissues. Apart from kidney, stomach is another target tissue of WTX gene. The germline and somatic mutations of WTX were screened in 12 gastric cancer patients and identified in one cases (8.3%). Mutation in the WTX gene might be one of the reasons of WTX loss in gastric cancer patients.

Entities:  

Keywords:  Immunohistochemical staining; In situ hybridization; Tumor suppressor; Wilms’ tumor suppressor X chromosome (WTX)

Mesh:

Substances:

Year:  2016        PMID: 28032309     DOI: 10.1007/s12253-016-0168-0

Source DB:  PubMed          Journal:  Pathol Oncol Res        ISSN: 1219-4956            Impact factor:   3.201


  23 in total

1.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

Authors:  K J Livak; T D Schmittgen
Journal:  Methods       Date:  2001-12       Impact factor: 3.608

2.  Expression patterns of the Wtx/Amer gene family during mouse embryonic development.

Authors:  Glenda Comai; Agnes Boutet; Yasmine Neirijnck; Andreas Schedl
Journal:  Dev Dyn       Date:  2010-06       Impact factor: 3.780

3.  New tumour suppressor linked to Wilms' tumour.

Authors:  Sanjit Bagchi
Journal:  Lancet Oncol       Date:  2007-02       Impact factor: 41.316

4.  An X chromosome gene, WTX, is commonly inactivated in Wilms tumor.

Authors:  Miguel N Rivera; Woo Jae Kim; Julie Wells; David R Driscoll; Brian W Brannigan; Moonjoo Han; James C Kim; Andrew P Feinberg; William L Gerald; Sara O Vargas; Lynda Chin; A John Iafrate; Daphne W Bell; Daniel A Haber
Journal:  Science       Date:  2007-01-04       Impact factor: 47.728

5.  A novel WTX mutation in a female patient with osteopathia striata with cranial sclerosis and hepatoblastoma.

Authors:  Atsushi Fujita; Nobuhiko Ochi; Hidehiko Fujimaki; Hideki Muramatsu; Yoshiyuki Takahashi; Jun Natsume; Seiji Kojima; Mitsuko Nakashima; Yoshinori Tsurusaki; Hirotomo Saitsu; Naomichi Matsumoto; Noriko Miyake
Journal:  Am J Med Genet A       Date:  2014-01-23       Impact factor: 2.802

6.  Cooperation between the thyroid hormone receptor TRalpha1 and the WNT pathway in the induction of intestinal tumorigenesis.

Authors:  Elsa Kress; Seham Skah; Maria Sirakov; Julien Nadjar; Nicolas Gadot; Jean-Yves Scoazec; Jacques Samarut; Michelina Plateroti
Journal:  Gastroenterology       Date:  2010-01-28       Impact factor: 22.682

7.  Promoter methylation of Wilms' tumor gene on the X- chromosome in gastric cancer.

Authors:  Xia Liu; Qiming Wang; Huilin Niu; Xuexi Yang; Jingzhe Sun; Qingling Zhang; Yanqing Ding
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2013-03

8.  Mutations in the WTX-gene are found in some high-grade microsatellite instable (MSI-H) colorectal cancers.

Authors:  Silvio K Scheel; Marc Porzner; Sabine Pfeiffer; Steffen Ormanns; Thomas Kirchner; Andreas Jung
Journal:  BMC Cancer       Date:  2010-08-09       Impact factor: 4.430

9.  Functional inactivation of the WTX gene is not a frequent event in Wilms' tumors.

Authors:  D Perotti; B Gamba; M Sardella; F Spreafico; M Terenziani; P Collini; A Pession; M Nantron; F Fossati-Bellani; P Radice
Journal:  Oncogene       Date:  2008-04-07       Impact factor: 9.867

10.  Expression of elevated levels of pro-inflammatory cytokines in SARS-CoV-infected ACE2+ cells in SARS patients: relation to the acute lung injury and pathogenesis of SARS.

Authors:  L He; Y Ding; Q Zhang; X Che; Y He; H Shen; H Wang; Z Li; L Zhao; J Geng; Y Deng; L Yang; J Li; J Cai; L Qiu; K Wen; X Xu; S Jiang
Journal:  J Pathol       Date:  2006-11       Impact factor: 7.996

View more
  5 in total

1.  MiR-4524b-5p/WTX/β-catenin axis functions as a regulator of metastasis in cervical cancer.

Authors:  Tong Li; Wenjuan Zhou; Yimin Li; Yaqi Gan; Yulong Peng; Qing Xiao; Chunli Ouyang; Anqi Wu; Sai Zhang; Jiaqi Liu; Lili Fan; Duo Han; Yu Wei; Guang Shu; Gang Yin
Journal:  PLoS One       Date:  2019-04-02       Impact factor: 3.240

2.  Mir20a/106a-WTX axis regulates RhoGDIa/CDC42 signaling and colon cancer progression.

Authors:  Gui-Fang Zhu; Yang-Wei Xu; Jian Li; Hui-Lin Niu; Wen-Xia Ma; Jia Xu; Pei-Rong Zhou; Xia Liu; Dan-Li Ye; Xiao-Rong Liu; Tao Yan; Wei-Ke Zhai; Zhi-Jun Xu; Chun Liu; Lei Wang; Hao Wang; Jia-Mao Luo; Li Liu; Xuan-Qi Li; Suiqun Guo; Hui-Ping Jiang; Peng Shen; Hui-Kuan Lin; Di-Hua Yu; Yan-Qing Ding; Qing-Ling Zhang
Journal:  Nat Commun       Date:  2019-01-10       Impact factor: 14.919

Review 3.  Wnt signaling in breast cancer: biological mechanisms, challenges and opportunities.

Authors:  Xiufang Xu; Miaofeng Zhang; Faying Xu; Shaojie Jiang
Journal:  Mol Cancer       Date:  2020-11-24       Impact factor: 27.401

4.  Mir-20a-5p induced WTX deficiency promotes gastric cancer progressions through regulating PI3K/AKT signaling pathway.

Authors:  Jian Li; Danli Ye; Peng Shen; Xiaorong Liu; Peirong Zhou; Guifang Zhu; Yangwei Xu; Yun Fu; Xuanqi Li; Jingbo Sun; Jia Xu; Qingling Zhang
Journal:  J Exp Clin Cancer Res       Date:  2020-10-08

5.  WTX inhibits gastric cancer migration through the reversal of epithelial-mesenchymal transition.

Authors:  Danli Ye; Wenxia Ma; Jiahui Xu; Guifang Zhu; Deying Liu; Chun Liu; Yanqing Ding; Qingling Zhang
Journal:  Oncol Lett       Date:  2018-08-16       Impact factor: 2.967

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.